Company Overview of Pfanstiehl, Inc.
Pfanstiehl, Inc. manufactures and supplies injectable grade excipients and bioprocessing solutions for the commercial manufacturing needs of biopharmaceutical companies in the United States and internationally. It specializes in isolation, purification, custom synthesis, and scale-up development of regulated, high purity, and low endotoxin injectable formulation ingredients, pharmaceutical intermediates and active pharmaceutical ingredients. The company manufactures high potency substances, high-purity and low-endotoxin carbohydrates, blocked sugars and derivatives, modified carbohydrates, polysaccharides and oligosaccharides, custom di-and tri-saccharides/complex carbohydrates, sugar acids,...
1219 Glen Rock Avenue
Waukegan, IL 60085-0439
Founded in 1919
Key Executives for Pfanstiehl, Inc.
Vice President of Operations
Vice President, Secretary and General Counsel
Compensation as of Fiscal Year 2014.
Pfanstiehl, Inc. Key Developments
Pfanstiehl Launches cGMP-Produced, Non-Animal-Derived Galactose for Optimizing Cell Culture Media
Mar 31 14
Pfanstiehl announced the launch of its new high purity, low endotoxin, non-animal-derived Galactose (USP/NF, EP), manufactured in the US under strict cGMP, ICH Q7 compliant conditions.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries